NurExone Biologic Inc.
NRXBF
$0.50
$0.011.05%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -32.18% | 3.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.54% | 7.18% | |||
| Operating Income | 19.54% | -7.18% | |||
| Income Before Tax | 20.64% | -10.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 20.64% | -10.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.64% | -10.01% | |||
| EBIT | 19.54% | -7.18% | |||
| EBITDA | 20.28% | -7.42% | |||
| EPS Basic | 22.22% | -6.58% | |||
| Normalized Basic EPS | 22.37% | -7.04% | |||
| EPS Diluted | 22.22% | -6.58% | |||
| Normalized Diluted EPS | 22.37% | -7.04% | |||
| Average Basic Shares Outstanding | 2.05% | 3.30% | |||
| Average Diluted Shares Outstanding | 2.05% | 3.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||